GeoffreyS.GladsteinMD

Rheumatology • Trumbull, CT

Physician

Join to view full profile

Dr. Gladstein is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Gladstein's full profile

Already have an account?

Office
5520 Park Ave, Suite WP2-100
Trumbull, CT 06611
Phone+1 203-371-5873

Fax+1 203-371-5874
Is this information wrong?

Education & Training

Albany Medical CenterFellowship, Rheumatology, 1976 - 1978
Albany Medical CenterResidency, Internal Medicine, 1973 - 1976
George Washington University School of Medicine and Health SciencesClass of 1973

Certifications & Licensure

CT State Medical License 1978 - 2024
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Rheumatology

Awards, Honors, & Recognition

Greenwich Magazine Castle Connolly, 2013-2014
Top Doctors: New York Metro Area Castle Connolly, 2009-2014
Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Fellow (FACR) American College of Rheumatology
Join now to see all

Clinical Trials

An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis Start of enrollment: 2013 Jun 27
Completed
Phase 3
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus Start of enrollment: 2014 Jan 01
Terminated
Phase 3
A Study to Evaluate the Efficacy and Safety of X0002 Spray in Subjects With Osteoarthritis Start of enrollment: 2014 Feb 01
Completed
Phase 2
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Chronic Plaque Psoriasis (PsO) Start of enrollment: 2014 Jun 16
Completed
Phase 3
Comparative Efficacy and Safety Study of GP2015 and Enbrel® in Patients With Rheumatoid Arthritis Start of enrollment: 2015 Feb 21
Completed
Phase 3
A Study of Ixekizumab (LY2439821) in bDMARD-Naive Participants With Radiographic Axial Spondyloarthritis Start of enrollment: 2016 May 02
Completed
Phase 3
Evaluation of the Efficacy and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo and Adalimumab, in Subjects With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate But Have Active Disease Start of enrollment: 2016 Jun 06
Completed
Phase 3
A Long Term Extension Study of Ixekizumab (LY2439821) in Participants With Axial Spondyloarthritis Start of enrollment: 2017 May 09
Completed
Phase 3
Join now to see all

Publications & Presentations

PubMed

Gangrene of a foot secondary to systemic lupus erythematosus with large vessel vasculitis.
Gladstein, G. S., Rynes, R. I., Parhami, N., Bartholomew, L. E.> ;J Rheumatol. 1979 Sep 01

Journal Articles

Abatacept in the treatment of patients with psoriatic arthritis: results of a six-month, multicenter, randomized, double-blind, placebo-controlled, phase II trial.
Mease P, Genovese MC, Gladstein G, Kivitz AJ, Ritchlin C, Tak PP, Wollenhaupt J, Bahary O, Becker JC, Kelly S, Sigal L, Teng J, Gladman D.:, Arthritis Rheum., 4/2012
Evaluation of abatacept administered subcutaneously in adults with active rheumatoid arthritis: impact of withdrawal and reintroduction on immunogenicity, efficacy and...
Kaine J, Gladstein G, Strusberg I, Robles M, Louw I, Gujrathi S, Pappu R, Delaet I, Pans M, Ludivico C.:, Ann Rheum Dis., 1/7/2012

Professional Memberships

American College of Rheumatology - ACR
Fellow

Other Languages

Spanish, Portuguese

Hospital Affiliations

Bridgeport HospitalBridgeport, Connecticut